Meta-Analysishigh evidence
Tenecteplase Beyond the 4.5-h Window for Patients with Acute Ischemic Stroke: An Updated Meta-Analysis of Randomized Controlled Trials.
CNS drugs·August 1, 2026·PMID 42307864
Why it mattersThis analysis provides pooled evidence supporting tenecteplase as an effective thrombolytic option in the extended time window, potentially expanding treatment eligibility for patients who currently have limited options.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled